Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic

European Journal of Pharmacology

Volumn 522, Issue 1-3, 2005, Pages 38-46

  Hough, Lindsay B ^a   Nalwalk, Julia W ^a   Lu, Qun ^b   Shan, Zhixing ^b   Svokos, Konstantina ^a   Wentland, Mark P ^b   Montero, M José ^c  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

H2 receptor; H2 receptor antagonist; Histamine; Improgan; Zolantidine

Indexed keywords

1 [3 (3 ANILINOPROPOXY)BENZYL]PIPERIDINE; 1 [3 [3 (2,2,2 TRIFLUOROETHYLAMINO)PROPOXY]BENZYL]PIPERIDINE; 2 [3 (3 PIPERIDINOMETHYLPHENOXY)PROPYLAMINO] 4(3H)QUINAZOLINONE; 2 [3 [3 (1 PIPERIDYLMETHYL)PHENOXY]PROPYLAMINO]PYRIDINE; 4 [3 [3 (1 PIPERIDYLMETHYL)PHENOXY]PROPYLAMINO]QUINAZOLINE; ANALGESIC AGENT; ANTIHISTAMINIC AGENT; IMPROGAN; JB 9322; LOXTIDINE; METHYL GROUP; UNCLASSIFIED DRUG; ZOLANTIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALGORITHMS; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BENZOTHIAZOLES; BRAIN; CIMETIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE H2 ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOLECULAR STRUCTURE; PAIN; PAIN MEASUREMENT; PHENOXYPROPANOLAMINES; PIPERIDINES; QUINAZOLINES; QUINAZOLINONES; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES; TIME FACTORS; TRIAZOLES;

EID: 26844517351     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.040     Document Type: Article

References (34)

1. G.J. Amabeoku, and O. Chikuni Cimetidine-induced seizures in mice. Antagonism by some GABAergic agents Biochem. Pharmacol. 46 1993 2171 2175
2. 2-receptor blocking drug Br. J. Pharmacol. 85 1985 843 847
3. 2-receptor antagonist Br. J. Pharmacol. 93 1988 69 78
4. K.E. Cannon, M.W. Fleck, and L.B. Hough Effects of cimetidine-like drugs on recombinant GABAA receptors Life Sci. 75 2004 2551 2558
5. L.A. Crane, and S.D. Glick Simple cannula for repeated intracerebral drug administration in rats Pharmacol. Biochem. Behav. 10 1979 799 800
6. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
7. N.B. Eddy, and D. Leimbach Synthetic analgesics, II dithienylbutenyl and dithienylbutylamines J. Pharmacol. Exp. Ther. 107 1953 385 393
8. C.R. Ganellin Chemistry and structure-activity relationships of drugs acting at histamine receptors C.R. Ganellin M.E. Parsons Pharmacology of Histamine Receptors 1982 John Wright and Sons, Ltd. Bristol 10 102
9. M.C. Gerald, and N.A. Richter Studies on the effects of histaminergic agents on seizure susceptibility in mice Psychopharmacologia 46 1976 277 282
10. 2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia Neuropharmacology 27 1988 357 362
11. 2 antagonists J. Pharmacol. Exp. Ther. 248 1989 262 267
12. L.B. Hough, S.D. Glick, and K.L. Su Cimetidine penetrates brain and inhibits non-opiate footshock-induced analgesia Pharmacol. Biochem. Behav. 24 1986 1257 1261
13. 3 antagonists and derivatives J. Pharmacol. Exp. Ther. 283 1997 1534 1543
14. L.B. Hough, J.W. Nalwalk, Y. Chen, A. Schuller, Y. Zhu, J. Zhang, W.M.P.B. Menge, R. Leurs, H. Timmerman, and J.E. Pintar Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice Brain Res. 880 2000 102 108
15. L.B. Hough, J.W. Nalwalk, R. Leurs, W.M.P.B. Menge, and H. Timmerman Antinociceptive activity of derivatives of improgan and burimamide Pharmacol. Biochem. Behav. 65 2000 61 66
16. L.B. Hough, J.W. Nalwalk, W.G. Barnes, R. Leurs, W.M. Menge, and H. Timmerman A third legacy for burimamide: discovery and characterization of improgan and a new class of non-opioid analgesics derived from histamine antagonists T. Watanabe H. Timmerman K. Yanai Histamine Research in the New Millenium 2001 Elsevier Amsterdam 237 242
17. L.B. Hough, J.W. Nalwalk, W.M. Menge, R. Leurs, and H. Timmerman Significance of GABAergic systems in the action of improgan, a non-opioid analgesic Life Sci. 68 2001 2751 2757
18. L.B. Hough, J.W. Nalwalk, R. Stadel, H. Timmerman, R. Leurs, B.C. Paria, X. Wang, and S.K. Dey Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)- 4-methyl-1H-p yrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors J. Pharmacol. Exp. Ther. 303 2002 314 322
19. E. Kutter Structure-activity correlations of morphine-like analgetics based on efficiencies following intravenous and intraventricular application J. Med. Chem. 13 1970 801 805
20. B.Y. Li, J.W. Nalwalk, L.A. Barker, P. Cumming, M.E. Parsons, and L.B. Hough Characterization of the antinociceptive properties of cimetidine and a structural analog J. Pharmacol. Exp. Ther. 276 1996 500 508
21. B.Y. Li, J.W. Nalwalk, J.M. Finkel, S.D. Glick, and L.B. Hough SKF92374, a cimetidine analog, produces mechanical and thermal antinociception in the absence of motor impairment Analgesia 3 1997 15 20
22. B.Y. Li, J.W. Nalwalk, and L.B. Hough Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats Brain Res. 748 1997 168 174
23. J.I. Mobarakeh, J.W. Nalwalk, T. Watanabe, S. Sakurada, M. Hoffman, R. Leurs, H. Timmerman, I. Silos-Santiago, K. Yanai, and L.B. Hough Improgan antinociception does not require neuronal histamine or histamine receptors Brain Res. 974 2003 146 152
24. J.W. Nalwalk, K. Svokos, R. Leurs, and L.B. Hough Absence of 5-HT3 and cholinergic mechanisms in improgan antinociception Pharmacol. Biochem. Behav. 80 2005 505 510
25. J.W. Nalwalk, K. Svokos, O. Taraschenko, R. Leurs, H. Timmerman, and L.B. Hough Activation of brain stem nuclei by improgan, a non-opioid analgesic Brain Res. 1021 2004 248 255
26. C. Netti, R. Bossa, I. Galatulas, V. Sibilia, and A. Pecile Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat Pharmacology 28 1984 262 267
27. 2-receptor antagonist Jpn. J. Pharmacol. 42 1986 229 235
28. 2-receptor antagonist with potent gastric mucosal protective properties Br. J. Pharmacol. 115 1995 57 66
29. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 2nd ed. 1986 Academic Press Sydney
30. J.J. Schentag, F.B. Cerra, G.M. Calleri, M.E. Leising, M.A. French, and H. Bernhard Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients Clin. Pharmacol. Ther. 29 1981 737 743
31. 2 receptor antagonists in mice Toxicol. Appl. Pharmacol. 136 1996 317 323
32. 2 adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic Brain Res. 921 2001 12 19
33. R.W. von Einsiedel, D. Roesch-Ely, K. Diebold, K. Sartor, C. Mundt, and N. Bergemann H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures Pharmacopsychiatry 35 2002 152 154
34. 2 receptor histamine antagonists J. Med. Chem. 31 1988 656 671